- Home
- MLYS vs CMPO Comparison
MLYS vs CMPO Comparison
Compare MLYS & CMPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- CMPO
- Stock Information
- Founded
- MLYS 2019
- CMPO 2000
- Country
- MLYS United States
- CMPO United States
- Employees
- MLYS N/A
- CMPO N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- CMPO Finance: Consumer Services
- Sector
- MLYS Health Care
- CMPO Finance
- Exchange
- MLYS Nasdaq
- CMPO Nasdaq
- Market Cap
- MLYS 1.0B
- CMPO 1.2B
- IPO Year
- MLYS 2023
- CMPO N/A
- Fundamental
- Price
- MLYS $13.48
- CMPO $13.95
- Analyst Decision
- MLYS Strong Buy
- CMPO Strong Buy
- Analyst Count
- MLYS 4
- CMPO 8
- Target Price
- MLYS $27.00
- CMPO $16.19
- AVG Volume (30 Days)
- MLYS 667.1K
- CMPO 803.3K
- Earning Date
- MLYS 08-12-2025
- CMPO 08-06-2025
- Dividend Yield
- MLYS N/A
- CMPO N/A
- EPS Growth
- MLYS N/A
- CMPO N/A
- EPS
- MLYS N/A
- CMPO N/A
- Revenue
- MLYS N/A
- CMPO $376,385,000.00
- Revenue This Year
- MLYS N/A
- CMPO $7.52
- Revenue Next Year
- MLYS N/A
- CMPO $7.91
- P/E Ratio
- MLYS N/A
- CMPO N/A
- Revenue Growth
- MLYS N/A
- CMPO N/A
- 52 Week Low
- MLYS $8.24
- CMPO $5.14
- 52 Week High
- MLYS $18.38
- CMPO $14.71
- Technical
- Relative Strength Index (RSI)
- MLYS 35.32
- CMPO 62.67
- Support Level
- MLYS $12.98
- CMPO $13.59
- Resistance Level
- MLYS $16.67
- CMPO $14.34
- Average True Range (ATR)
- MLYS 0.81
- CMPO 0.37
- MACD
- MLYS -0.33
- CMPO -0.06
- Stochastic Oscillator
- MLYS 13.56
- CMPO 58.74
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.